MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishikawa, Y.
Right arrow Articles by Ishida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishikawa, Y.
Right arrow Articles by Ishida, H.

Vol. 61, Issue 6, 1423-1434, June 2002

The Muscarinic Acetylcholine Receptor-Stimulated Increase in Aquaporin-5 Levels in the Apical Plasma Membrane in Rat Parotid Acinar Cells Is Coupled with Activation of Nitric Oxide/cGMP Signal Transduction

Yasuko Ishikawa, Hirokazu Iida, and Hajime Ishida

Department of Pharmacology, Tokushima University School of Dentistry, Tokushima, Japan

The present study investigated the role of nitric oxide (NO)/cGMP signal transduction in the M3 muscarinic acetylcholine receptor (mAChR)-stimulated increase in aquaporin-5 (AQP5) levels in the apical plasma membrane (APM) of rat parotid glands. Pretreatment of rat parotid tissue with the NO scavenger 2-(4carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide potassium inhibited both acetylcholine (ACh)- and pilocarpine-induced increases in AQP5 in the APM. NO donors [3-morpholinosydnonimine (SIN-1) and (S)-nitroso-N-acetylpenicillamine (SNAP)] mimicked the effects of mAChR agonists. A selective protein kinase G inhibitor [(9S,10R,12R)-2,3,9,10,11,12-hexahydro-10-methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo-[1,2,3-fg-3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester (KT5823)] and an NO synthase inhibitor (N6-imminoethyl-L-lysine) blocked SIN-1- and SNAP-induced increases in AQP5 in the APM. A calmodulin kinase II inhibitor [(8)-5-isoquinolinesulfonic acid, 4-[2-(5-isoquinolinyl-sulfonyl)methylamino]-3-oxo-(4-phenyl-1-piperazinyl)-propyl]phenyl ester (KN-62)] decreased the pilocarpine-induced increase of AQP5 in the APM. Using diaminofluorescinein-2 diacetate, enhanced NO synthase activity was detected in isolated parotid acinar cells after ACh-treatment. Treatment with dibutyryl cGMP, but not dibutyryl cAMP, induced an increase in AQP5 levels in the APM. BAPTA-AM inhibited the cGMP-induced increase in AQP5 in the APM. Pretreatment of the tissues with a myosin light chain kinase inhibitor [(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine (ML-9)] inhibited a mAChR-stimulated increase in AQP5 levels in the APM. Although there was a significant ACh-induced increase in AQP5 in the APM in the absence of extracellular Ca2+, the maximal effect of ACh on the AQP5 levels in the APM occurred in the presence of extracellular Ca2+. These results suggest that NO/cGMP signal transduction has a crucial role in Ca2+ homeostasis in the mAChR-stimulated increase in AQP5 levels in the APM of rat parotid glands.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
L. J. Dawson, P. C. Fox, and P. M. Smith
Sjogrens syndrome--the non-apoptotic model of glandular hypofunction
Rheumatology, July 1, 2006; 45(7): 792 - 798.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Ishikawa, Z. Yuan, N. Inoue, M. T. Skowronski, Y. Nakae, M. Shono, G. Cho, M. Yasui, P. Agre, and S. Nielsen
Identification of AQP5 in lipid rafts and its translocation to apical membranes by activation of M3 mAChRs in interlobular ducts of rat parotid gland
Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1303 - C1311.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Sidhaye, J. D. Hoffert, and L. S. King
cAMP Has Distinct Acute and Chronic Effects on Aquaporin-5 in Lung Epithelial Cells
J. Biol. Chem., February 4, 2005; 280(5): 3590 - 3596.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
N. Inoue, H. Iida, Z. Yuan, Y. Ishikawa, and H. Ishida
Age-related Decreases in the Response of Aquaporin-5 to Acetylcholine in Rat Parotid Glands
J. Dent. Res., June 1, 2003; 82(6): 476 - 480.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics